Generic for multaq?

What is the Generic for Multaq?

Multaq, also known as Dronedarone, is an antiarrhythmic medication used to treat certain types of irregular heartbeats. The generic for Multaq was approved by the FDA in 2018 [1]. The generic versions of dronedarone are manufactured by various pharmaceutical companies, such as Mylan Pharmaceuticals and Aurobindo Pharma [2]. According to DrugPatentWatch.com, the first patent for Multaq expired in 2018, allowing generic versions to be marketed.

How does the Generic Version Compare with Branded Multaq?

Generic versions of Multaq are similar to the branded version in terms of their active ingredient, dronedarone. However, generic drugs may differ in their inactive ingredients, manufacturing process, or packaging. It is essential to consult with a healthcare professional or pharmacist to ensure that the generic version is suitable for your specific needs.

What Side Effects are Patients Asking About?

Common side effects of Multaq (and its generic versions) include diarrhea, nausea, vomiting, abdominal pain, and headache. More severe side effects may include kidney problems, liver damage, and heart rhythm changes. It is crucial to report any side effects or concerns to your healthcare provider.

When Does Exclusivity Expire?

The exclusivity for Multaq, granted by the FDA's 505(b)(2) approval pathway, expired in 2018. This means that generic versions can be marketed and sold without the original manufacturer's exclusive rights.

Sources:
[1] FDA. (2018). Dronedarone Tablets.
[2] DrugPatentWatch.com.

Note: The information provided is accurate as of my cut-off knowledge date (December 2023) and may have changed since then.